Transcatheter mitral valve repair in patients with CKD

A post hoc analysis of the COAPT trial suggests that transcatheter mitral valve repair for secondary mitral regurgitation is efficacious in patients with heart failure and chronic kidney disease. The intervention also reduced the risk of kidney failure, raising hypotheses regarding the mechanisms th...

Full description

Saved in:
Bibliographic Details
Published in:Nature reviews. Nephrology 2022-08, Vol.18 (8), p.483-484
Main Authors: McCallum, Wendy, Sarnak, Mark J.
Format: Article
Language:English
Subjects:
692/4019
692/4022/1950
Ejection fraction
Heart failure
Hemodynamics
Hypotheses
Kidney diseases
Medicine
Medicine & Public Health
Mortality
Nephrology
News & Views
news-and-views
Observational studies
Patients
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A post hoc analysis of the COAPT trial suggests that transcatheter mitral valve repair for secondary mitral regurgitation is efficacious in patients with heart failure and chronic kidney disease. The intervention also reduced the risk of kidney failure, raising hypotheses regarding the mechanisms that link heart failure and loss of kidney function.
ISSN:1759-5061
1759-507X
DOI:10.1038/s41581-022-00583-y